Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportInstrumentation & Data Analysis

Assessment of AI-Enhanced Quantitative Volumetric MRI with Semi-Quantitative Analysis in 18F-FDG Metabolic Imaging for Alzheimer's Diagnosis.

Natchaphorn Onthaworn, Attapon Jantarato, Pimlapat Panperee, Sunpob Cheewadhanaraks, Laksika Bunthathorn, Dheeratama Siripongsatian and Chanisa Chotipanich
Journal of Nuclear Medicine June 2024, 65 (supplement 2) 24128;
Natchaphorn Onthaworn
1Chulabhorn Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Attapon Jantarato
2National Cyclotron and PET Centre, Chulabhorn Hospital, Thailand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pimlapat Panperee
2National Cyclotron and PET Centre, Chulabhorn Hospital, Thailand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sunpob Cheewadhanaraks
1Chulabhorn Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laksika Bunthathorn
1Chulabhorn Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dheeratama Siripongsatian
2National Cyclotron and PET Centre, Chulabhorn Hospital, Thailand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chanisa Chotipanich
2National Cyclotron and PET Centre, Chulabhorn Hospital, Thailand
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

24128

Introduction: The integration of Magnetic Resonance Imaging (MRI) and Positron Emission Tomography (PET) data, coupled with advancements in artificial intelligence (AI), has significantly enhanced the semi-quantitative aspects of morphologic imaging. This study systematically scrutinizes the diagnostic precision of quantitative MRI, employing the AI tool "Heuron AD" for automated volumetric measurements. The primary objective is to discern the clinical efficacy of Heuron AD and its potential for early Alzheimer's disease (AD) detection in 18F-FDG PET metabolic imaging.

15 AD patients (6 men, 9 women; mean age ± SD: 70.4 ± 9.72) and 15 normal subjects (5 men, 10 women; mean age ± SD: 66.73 ± 7.99) were enrolled, aged 54-84 years and 51-80 years, respectively. PET images were acquired at 50-60 minutes after 18F-FDG injection. The Heuron AD software was used to extract brain volume. P-mod software was used to compute standardized uptake value ratio (SUVr) and software was used to calculate Z scores to compare FDG uptake. Stata software was employed to find the correlation between extracted brain volume, SUVr, and Z scores. Two experienced radiologists, blinded to clinical information, performed visual interpretations of the MRI images. AD patients were identified by using the ATN system. MRI images were obtained using Siemens mMR PET/MRI.

Methods: 15 AD patients (6 men, 9 women; mean age ± SD: 70.4 ± 9.72) and 15 normal subjects (5 men, 10 women; mean age ± SD: 66.73 ± 7.99) were enrolled, aged 54-84 years and 51-80 years, respectively. PET images were acquired at 50-60 minutes after 18F-FDG injection. The Heuron AD software was used to extract brain volume. P-mod software was used to compute standardized uptake value ratio (SUVr) and software was used to calculate Z scores to compare FDG uptake. Stata software was employed to find the correlation between extracted brain volume, SUVr, and Z scores. Two experienced radiologists, blinded to clinical information, performed visual interpretations of the MRI images. AD patients were identified by using the ATN system. MRI images were obtained using Siemens mMR PET/MRI.

Results: The software yielded a balanced sensitivity and specificity for detection of Alzheimer's-related changes in hippocampal volume with a good accuracy (73.33%) compared to 66.67% accuracy (46.67% sensitivity, 86.67% specificity) by radiologists. Brain volume examination in the identified AD signature area also revealed 66.67% accuracy (33.33% sensitivity, 100% specificity). The atrophy index, a measure of shrinkage, of hippocampal volume using Heuron AD, notably correlated with FDG SUVr in the hippocampus. The hippocampal Z-score moderately correlated with the atrophy index. There was also moderate correlation of atrophy index from Heuron AD’s brain signature area with FDG SUVr. However, no correlation was observed between the atrophy index from the brain signature area and the Z-score The diagnostic performance, indicated by the area under the curve (AUC), was 0.83 for hippocampal atrophy, 0.81 for the AD signature area, 0.82 for SUVr, and 0.59 for Z-score calculation.

Conclusions: The software exhibits promising potential for detection of Alzheimer's-related hippocampal volume loss, outperforming radiologists’ interpretations with an accuracy of 73.33% and the highest AUC compared with all methods. Notably, there is a strong correlation of Heuron AD's hippocampal atrophy index and FDG SUVr values, highlighting its sensitivity to subtle atrophy. The use of AI with radiologists collaboratively holds the promise of enhancing precision and sensitivity in the diagnosis of Alzheimer’s Disease. However, ongoing development remains paramount for optimizing the software, particularly in refining the analysis method of signature brain AD area where enhancements in sensitivity may be imperative.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 65, Issue supplement 2
June 1, 2024
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Assessment of AI-Enhanced Quantitative Volumetric MRI with Semi-Quantitative Analysis in 18F-FDG Metabolic Imaging for Alzheimer's Diagnosis.
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Assessment of AI-Enhanced Quantitative Volumetric MRI with Semi-Quantitative Analysis in 18F-FDG Metabolic Imaging for Alzheimer's Diagnosis.
Natchaphorn Onthaworn, Attapon Jantarato, Pimlapat Panperee, Sunpob Cheewadhanaraks, Laksika Bunthathorn, Dheeratama Siripongsatian, Chanisa Chotipanich
Journal of Nuclear Medicine Jun 2024, 65 (supplement 2) 24128;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Assessment of AI-Enhanced Quantitative Volumetric MRI with Semi-Quantitative Analysis in 18F-FDG Metabolic Imaging for Alzheimer's Diagnosis.
Natchaphorn Onthaworn, Attapon Jantarato, Pimlapat Panperee, Sunpob Cheewadhanaraks, Laksika Bunthathorn, Dheeratama Siripongsatian, Chanisa Chotipanich
Journal of Nuclear Medicine Jun 2024, 65 (supplement 2) 24128;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Exploring the impact of feature selection methods and classification algorithms on the predictive performance of PET radiomic ML models in lung cancer
  • Accuracy of 177Lu-DOTATATE PRRT absorbed dose estimation by reducing the imaging points
Show more Instrumentation & Data Analysis

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire